Buy & Sell Brigit Biofarmaka Teknologi Tbk. - OBAT Share Price Today
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Revenue | Rp160.12B | +32.74% |
| Cost of Revenue | Rp97.26B | +54.99% |
| Gross Profit | Rp62.86B | +8.61% |
| General Expenses, Depreciation, Interest | Rp30.38B | +54.28% |
| Operating Profit | Rp32.47B | -14.95% |
| Other Income | Rp380.52M | -71.74% |
| EBT | Rp32.85B | -16.89% |
| Taxes | -Rp7.27B | -180.52% |
| Net Income | Rp22.64B | -23.05% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Total Assets | Rp131B | +98.83% |
| Total Liabilities | Rp20.99B | -5.44% |
| Total Equity | Rp106.93B | +153.02% |
| Total Liabilities & Total Equity | Rp127.92B | +98.46% |
Cash Flow
Operating
Investing
Finance
Net CF
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| CF from Operations | Rp23.72B | +83.02% |
| CF from Investment | Rp34.73B | +292.38% |
| CF from Financing | Rp33.95B | -2064.33% |
| Net Cash Flow | Rp22.95B | +862.7% |